Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch
NCT01191359
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy
Interventions
BIOLOGICAL:
oral immunotherapy
Sponsor
ALK-Abelló A/S